Contact
For business, media, or testing-related inquiries, please get in touch.
ELEVATE INDUSTRY HEALTH & SAFETY STANDARDS WITH C-POLAR™ REVOLUTIONARY PROTECTION AGAINST VIRUSES, MICROORGANISMS, AND POLLENS
REVOLUTIONARY PROTECTION AGAINST VIRUSES, BACTERIA, MOLDS, FUNGI, AND POLLENS
* Based on third-party studies, internal testing, and data from commercial installations
The pandemic, recent wildfires, and air pollution have shown how unhealthy indoor air can be. But scientific and governmental inertia have slowed the necessary remedies.
Read more
Why We're Still Breathing Dirty Indoor Air (Article by The New York Times)
Recommended article
The study showed C-POLAR™ treated filtration material inactivated 99.4% of pseudo-type SARS CoV-2 and also increased the filtration efficiency of the filtration media from 74.2% to 97.2%.
Read more
Peer-reviewed study shows the effectiveness of C-POLAR filter media
Validation
Dr. Michael Mansour, Associate Professor of Medicine at Harvard Medical School, was featured on Canada's CTV News. He discussed technologies like C-POLAR™, which protect against the next pandemic.
Read more
Dr. Michael Mansour featured on CTV News
Media interview
A century ago, a well-ventilated building was considered good medicine. But by the time Covid-19 arrived, our buildings could barely breathe. How do we let the fresh air back in?
Read more
The New War on Bad Air (Article by The New York Times)
Recommended article
C-POLAR was featured on Global News. Senior Director of National Sales, Sam Chung, and Dr. Alan Rabinowitz of St. Paul's Hospital delved into our revolutionary technology.
Read more
C-POLAR featured on Global News with Sonia Sunger
Media interview
Who We Are
C-POLAR Technologies, Inc. provides bioprotection solutions.
Studies show our patent-pending technology,
C-POLAR™, captures, inactivates, and eradicates up to 99.99% of viruses, bacteria, molds, fungi, and pollens.*
We create infection-resilient environments, setting the global standard for health and safety for governments, private enterprises, hospitals, and schools.
*Based on third-party studies, internal testing, and data from commercial installations
Trusted By Global Organizations
NHS
NHS, including Tyneside Surgical Services, is the UK's publicly-funded healthcare system.
BGIS
BGIS is one of the largest facilities management and real estate services company globally.
MIAMI INTERNATIONAL AIRPORT
Miami International Airport is one of the largest airports in North America.
THE GRAND HYATT HK
The Grand Hyatt HK is a five-star, luxury hotel with branches across the world.
HANG LUNG PROPERTIES
Hang Lung Properties is a leading property developer in Hong Kong and Mainland China.
AFL-CIO, METAL TRADES
The Metal Trades Department is part of the AFL-CIO, the largest federation of US unions.
Proven Effective Against
COVID
19
Staphylococcus aureus
Escherichia
coli
Pseudomonas aeruginosa
Coxsackievirus B6
MECHANISM OF ACTION
C-POLAR™ is created using a WHO and UN FAO approved food-additive. Using our patent-pending, proprietary methodology, we apply C-POLAR™ onto selected materials, imbuing them with a stable positive charge. Multiple studies have shown that C-POLAR™ treated materials effectively capture, inactivate, and eradicate viruses, microorganisms, and pollens with high efficiency.
CAPTURE
Studies show the negatively charged virus, microorganism, or pollen is attracted via C-POLAR™ material’s positive polarity and captured upon contact.
INACTIVATE
Studies show the negatively charged virus, microorganism, or pollen is inactivated as the C-POLAR™ material tears away the envelope and destroys the protein membrane.
ERADICATE
Studies show the protein envelope and/or protein membranes are then disintegrated, destroying the virus, microorganism, or pollen.
Our Advantages
C-POLAR™ is based on fundamental physics. Studies show C-POLAR™ can capture, inactivate, and eradicate up to 99.99% of viruses, microorganisms, and pollens.
- Highly-Effective Against Viruses, Microorganisms, and Pollens
- Versatile Application
- Economical
- Safe For Human Use
Quote from Dr. MICHAEL K. Mansour
